Pathways
Diabetes
Metformin
FirstFirst Line
SGLT2 inhibitors
FirstFirst Line
SecondAlternatives
GLP-1 / GIP receptor agonists
FirstFirst Line
SecondSecond Line
ThirdAlternatives
Diabetic neuropathy
FirstFirst Line
SecondSecond Line
ThirdThird Line
FourthAlternatives